Uterine fibroids are one of the most common benign tumors in the female pelvis, also known as uterine smooth muscle tumors. Medical data show that the incidence of uterine fibroids is about 20% in women over 35 years of age, and the incidence has increased significantly in recent years. The cause of the disease is not exact, but may be related to long-term estrogen stimulation. Many patients are asymptomatic and are only detected during physical examination. If they have symptoms, they are mainly manifested in the following aspects: first, excessive menstruation, prolonged periods or shortened cycles, which may lead to secondary anemia in the long term; second, lower abdominal masses; symptoms of pressure on adjacent organs, such as frequent urination, urgent urination, or even difficult urination and constipation; and also increased leucorrhea, abdominal pain or dysmenorrhea, infertility, etc. Adenomyosis, also known as intrinsic endometriosis, also has a higher incidence in women. It is formed when the endometrium grows in the myometrium due to abortion, childbirth and other pathologies. The ectopic endometrium changes with the cycle of ovarian hormones and has a proliferation and secretion period, and bleeding occurs during menstruation, and the blood cannot be discharged like menstruation, resulting in reactive proliferation of surrounding tissues, which causes corresponding symptoms, mainly manifesting as increased menstrual flow and prolonged periods, secondary and progressive dysmenorrhea, which seriously affects women’s physical and mental health. The traditional treatment for both diseases includes hysterectomy and hormone therapy, and myomectomy can also be used to remove fibroids, but the recurrence rate is high; hysterectomy has certain complications, and some patients, especially young patients, have difficulty in accepting premature removal of the uterus; hormone therapy has only short-term efficacy and many side effects, so it is not preferred. In recent years, interventional techniques have been applied to the treatment of uterine tumors and adenomyosis, which are popular among patients as they can eliminate symptoms and preserve the uterus at the same time, giving it a second life. The method is to puncture the femoral artery through a needle like we usually use for a hangnail, and then use a guide wire to introduce a thin catheter into the bilateral uterine arteries and inject different embolic agents to block the arteries supplying blood to the uterine fibroids or ectopic endometrium, so that the lesions are not nourished and “starved to death”. Under the high standard of technology and equipment, this method is safe, without serious complications, and can quickly relieve symptoms, with an overall efficiency of more than 90% in controlling symptoms, including the complete return of normal menstruation, the reduction or disappearance of pressure symptoms, and the disappearance of pain. Patients with adenomyosis can have complete relief of dysmenorrhea, and the fibroids start to shrink in 1 month after embolization, and shrink significantly in 3-6 months, reaching about 60%, and no recurrence is seen in 1-2 years of follow-up cases.